Arix Bioscience Investor

Venture capital firm


Investors

Founded Date: 2015
Technology: Geroscience
Investor Type: Venture Capital
Funding Status: IPO
Total Funding: 21438354 USD
Employee Number: 11-50
Headquarters: London, England, United Kingdom
Last Funding Date: 2018-04-04
Last Funding Type: Post-IPO Equity
Estimated Revenue: $1M to $10M
Number Of Exists: 6
Industry: Biotechnology, Financial Services, Health Care, Lending and Investments, Science and Engineering